Test Price
190 AED✅ Home Collection Available
Immunohistochemistry Estrogen Receptor (ER) Test in UAE | 190 AED | DHA Licensed
Executive Summary & Core Metrics
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑accredited immunohistochemistry with digital pathology scoring, validated against ASCO/CAP guidelines.
- ✓ Premium Logistics: Secure Medical Courier Retrieval of Formalinfixed paraffin‑embedded tissue blocks or biopsy slides from any hospital in the UAE.
- ✓ Clinical Guidance: Telephonic post‑test clinical guidance in result interpretation with a DHA‑licensed specialist.
- ✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Immunohistochemistry Estrogen Receptor (ER) Test precisely measures the percentage and intensity of cancer cells expressing estrogen receptors, directly guiding endocrine therapy (tamoxifen / aromatase inhibitors) for breast cancer management. Our laboratory uses automated digital image analysis with DAB chromogen detection, ensuring quantitative, reproducible results aligned with international guidelines.
| Feature | Our Test (DNA Labs UAE) | Closest Alternative |
|---|---|---|
| Diagnostic Precision | 99.9% Sensitivity – FDA‑cleared antibodies + automated digital scoring | Manual scoring, inter‑observer variability, often ≤95% concordance |
| Methodology | IHC with quantitative image analysis (DAB chromogen), ASCO/CAP aligned | Traditional IHC, semi‑quantitative visual estimation |
| Result Turnaround | 5 days (standard FFPE block), 5 days (biopsy slide), 7 days (complex cases) | 7–10 days without dedicated pathology algorithm |
| UAE Compliance | Fully DHA/MOHAP approved, ISO 9001:2015 | Variable; may lack local regulatory pedigree |
Physician Insight & Safety Protocols
“As a clinician, I understand that waiting for receptor status can be deeply stressful. The ER test is not a standalone diagnosis but a critical companion to histopathology—it shapes the entire treatment roadmap. I encourage all patients to discuss results within a multidisciplinary tumour board context.” – Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011.
Medication Advisory
Do not discontinue or alter prescribed endocrine therapy (e.g., tamoxifen, aromatase inhibitors) based solely on this test result without consulting your treating oncologist. This test informs treatment selection but should never replace clinical judgment.
Exclusion Criteria & Red Flags
- Insufficient tumour cellularity (less than 50 invasive cells) – sample rejected.
- Decalcified or necrotic tissue – may yield false negative ER result.
- Metastatic lesion with history of ER‑positive primary – repeat biopsy mandatory.
- If bleeding, swelling, or signs of infection occur at biopsy site, seek immediate emergency care.
- New pain, shortness of breath, or neurological symptoms while waiting for result – proceed to ER.
Patient FAQ & Clinical Guidance
1. What does the Estrogen Receptor (ER) test result tell my oncologist?
The ER test quantifies the percentage of cancer cells expressing estrogen receptors, directly predicting benefit from endocrine therapy and serving as a core prognostic marker. A positive result (typically ≥1%) indicates that hormone therapy may be effective; a negative result suggests alternative treatments should be prioritised.
2. How is the test performed and when will I get the report?
Using a small portion of your existing biopsy tissue (FFPE block or slide), our pathology team applies a special antibody that binds to estrogen receptors. Automated digital scoring ensures a standard 5‑day turnaround for most specimens. Results are delivered via secure online portal and telephone consultation.
3. How is my tissue sample safely transported to DNA Labs UAE?
Our secure medical courier service retrieves your archival tissue block or biopsy slide directly from your hospital pathology department. Temperature‑controlled packaging and chain‑of‑custody documentation guarantee specimen integrity throughout transit.
UAE Regulatory & Data Privacy Adherence
Data Protection & Health Information Security: DNA Labs UAE complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree‑Law No. 4 of 2016 on Medical Liability. Our laboratory holds DHA Facility License No. 1143 and is ISO 9001:2015 certified.
Clinical & Logistical Metadata
| Test Name | Immunohistochemistry Estrogen Receptor (ER) |
| Price (AED) | 190 |
| Turnaround Time | 5 business days (standard specimens) |
| Sample Type / Matrix | Formalin-fixed paraffin-embedded (FFPE) tissue block or biopsy slide (archival specimen) |
| Methodology Used | Immunohistochemistry (IHC) with automated digital image analysis, DAB chromogen detection |
| ICD-10-CM Code | C50.9 (Malignant neoplasm of breast, unspecified) |
| LOINC Code | 16112-5 (Estrogen receptor [Interpretation] in Tissue by Immune stain) |
| DHA Facility License & Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians